These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9236248)

  • 1. Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.
    Nishino S; Arrigoni J; Shelton J; Kanbayashi T; Dement WC; Mignot E
    J Neurosci; 1997 Aug; 17(16):6401-8. PubMed ID: 9236248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic oral administration of CG-3703, a thyrotropin releasing hormone analog, increases wake and decreases cataplexy in canine narcolepsy.
    Riehl J; Honda K; Kwan M; Hong J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Jul; 23(1):34-45. PubMed ID: 10869884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
    Shelton J; Nishino S; Vaught J; Dement WC; Mignot E
    Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans.
    Nishino S; Riehl J; Hong J; Kwan M; Reid M; Mignot E
    Neurosci Res; 2000 Dec; 38(4):437-46. PubMed ID: 11164570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Narcolepsy].
    Billiard M; Cadilhac J
    Rev Neurol (Paris); 1985; 141(8-9):515-27. PubMed ID: 2868518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics.
    Black SW; Schwartz MD; Chen TM; Hoener MC; Kilduff TS
    Biol Psychiatry; 2017 Nov; 82(9):623-633. PubMed ID: 27919403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 mechanisms in canine narcolepsy.
    Nishino S; Arrigoni J; Valtier D; Miller JD; Guilleminault C; Dement WC; Mignot E
    J Neurosci; 1991 Sep; 11(9):2666-71. PubMed ID: 1831837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep.
    Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.
    Nishino S; Tafti M; Reid MS; Shelton J; Siegel JM; Dement WC; Mignot E
    J Neurosci; 1995 Jul; 15(7 Pt 1):4806-14. PubMed ID: 7623112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
    Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
    Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axis.
    Nemeroff CB; Bissette G; Martin JB; Brazeau P; Vale W; Kizer JS; Prange AJ
    Neuroendocrinology; 1980 Apr; 30(4):193-9. PubMed ID: 6769064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
    Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y
    Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narcolepsy: pathophysiology and pharmacology.
    Nishino S
    J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential affinities of TRH analogs at the mammalian spinal cord TRH receptor: implications for therapy in spinal injuries.
    Sharif NA; To Z; Michel AD; Whiting RL
    Neurosci Lett; 1989 Sep; 104(1-2):183-8. PubMed ID: 2554219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thyrotropin-releasing hormone on serum concentrations of thyroxine and triiodothyronine in healthy, thyroidectomized, thyroxine-treated, and propylthiouracil-treated dogs.
    Li WI; Chen CL; Tiller AA; Kunkle GA
    Am J Vet Res; 1986 Jan; 47(1):163-9. PubMed ID: 3080928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy.
    Kanbayashi T; Honda K; Kodama T; Mignot E; Nishino S
    Neuroscience; 2000; 99(4):651-9. PubMed ID: 10974428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
    Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
    Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs.
    Mitler MM; Dement WC
    Electroencephalogr Clin Neurophysiol; 1977 Nov; 43(5):691-9. PubMed ID: 72649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.